Vatican lays out 20 points for a universal and fair destination of vaccines, for a fairer and healthier world
Women advancing the end of AIDS
New funding requirements: CHF 2.8 billion IFRC-wide of which CHF 670 million is channelled through the IFRC Emergency Appeal in support of National Societies
Resource Kit for Field workers
J Pharm Pharm Sci (www.cspsCanada.org) 16(3) 441 - 455, 2013
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English...
Resistant bacteria are spreading worldwide. In collaboration with partners in India, Tanzania, South Africa and Germany, we have investigated the causes and consequences of this spread.2 This Pharma-Brief Special presents the results. It examines the risks for humans, animals and the environment. It focuses on local problems and approaches, international interactions and the re-sponsibility of doctors, farmers and consumers.
more
Background paper 11
The Independent Panel for Pandemic Preparedness and Response
May 2021
As of 21 May 2020, 4.8 million confirmed cases of Coronavirus disease 2019 (COVID-19) have been reported globally. In South America, COVID-19 was first detected on 26 February 2020, when Brazil confirmed a case in São Paulo.
With focus on creating linkages between social cash transfer programmes and HIV services
Accessed: 21.08.2019
Three Years After Enactment of the Drug Quality and Security Act